Cancer Research Landon Prizes for Basic and Translational Cancer Research  Tumor Immunology: New Perspectives
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 49, 560-564, February 1, 1989]
© 1989 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gigli, M.
Right arrow Articles by Manfait, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gigli, M.
Right arrow Articles by Manfait, M.

Correlation between Growth Inhibition and Intranuclear Doxorubicin and 4'-Deoxy-4'-iododoxorubicin Quantitated in Living K562 Cells by Microspectrofluorometry

Mauro Gigli1, Teddy W. D. Rasoanaivo, Jean-Marc Millot, Pierre Jeannesson, Vincenzo Rizzo, Jean-Claude Jardillier, Federico Arcamone2 and Michel Manfait

Laboratory of Biomolecular Spectroscopy [T. W. D. R., J-M. M., M. M.] and Biochemistry Laboratory [P. J., J-C. J.], Faculty of Pharmacy, 51, rue Cognacq Jay, 51096 Reims Cedex, France; and Farmitalia-C. Erba, R & D-Erbamont Group [V. R., F. A.], via dei Gracchi 35, 20146 Milan, Italy

Intranuclear drug concentration in cells treated with doxorubicin (DXR) or with 4'-deoxy-4'-iododoxorubicin (IDX) was measured by means of a quantitative microspectrofluorometric technique recently developed by us. Resolution of free and bound drug contributions in fluorescence emission spectra, as collected from a microvolume of single living cell nuclel, provided concentration data with about 10% indetermination. Uptake of DXR and IDX into the nucleus of K562 cells and DXR-resistant K562/DXR cells could then be studied with a sensitive, nondestructive technique. Growth inhibitory concentrations of K562 and K562/DXR cells, when measured with respect to drug content in the medium, differed by a factor of 25 in the case of DXR and by a factor of three in the case of IDX. By contrast, intranuclear drug concentrations measured at corresponding growth inhibitory concentrations are found to be nearly constant, i.e., independent of cellular-resistant phenotype and of anthracycline structure. This result supports an identical mechanism of action for the two drugs, most probably targeted to the nucleus, and ascribes to intracellular transport the different potency of the two drugs in the two cell lines.

1 Temporarily on staff at the Laboratory of Biomolecular Spectroscopy. Permanent address: Farmitalia-C. Erba R & D-Erbamont Group, via dei Gracchi 35, I-20146 Milan, Italy.

2 Present address: Menarini Ricerche Sud, via Tito Speri 10, 00040 Pomezia, Roma, Italy.

Received 5/25/88. Revised 10/ 6/88. Accepted 10/13/88.




This article has been cited by other articles:


Home page
J. Histochem. Cytochem.Home page
R. Belhoussine, H. Morjani, J. M. Millot, S. Sharonov, and M. Manfait
Confocal Scanning Microspectrofluorometry Reveals Specific Anthracyline Accumulation in Cytoplasmic Organelles of Multidrug-resistant Cancer Cells
J. Histochem. Cytochem., December 1, 1998; 46(12): 1369 - 1376.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1989 by the American Association for Cancer Research.